High Risk Chordoma
Showing 51 - 75 of >10,000
Breast Cancer Trial in Shanghai (Regional lymph node radiotherapy, chest/whole breast irradiation)
Recruiting
- Breast Cancer
- Regional lymph node radiotherapy
- chest/whole breast irradiation
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai jiaotong univestigy school of medicine
Aug 3, 2023
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Intermediate to High-risk Asymptomatic Sportsmen With Exercise
Completed
- Electrocardiography
- Screening stress test on a bicycle ergometer (usual practise)
-
Saint-Étienne, FranceCentre Hospitalier de Saint-Etienne
Sep 6, 2023
Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)
Not yet recruiting
- Prostate Cancer
- Radical Prostatectomy
- REGN5678
- Piflufolastat F18
-
Houston, TexasMD Anderson Cancer Center
Oct 10, 2023
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
Patients With Ultra High Risk of Psychotic Transition Trial in Poitiers (Cerebral MRI with Phosphorus 31 Magnetic Resonance
Not yet recruiting
- Patients With Ultra High Risk of Psychotic Transition
- Cerebral MRI with Phosphorus 31 Magnetic Resonance Spectroscopy
-
Poitiers, FranceCentre Hospitalier Henri Laborit
May 9, 2023
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Pegylated Liposomal Doxorubicin
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2023
Infections, Urinary Tract, Nephrolithiasis Trial in San Francisco (Duration of antibiotics)
Not yet recruiting
- Infections, Urinary Tract
- Nephrolithiasis
- Duration of antibiotics
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 20, 2023
Program to Identify Participants at High Risk for Amyloid
Not yet recruiting
- Alzheimer's Disease
- No Intervention
-
Lady Lake, Florida
- +1 more
Sep 12, 2023
Carotid Doppler Findings of High Risk Group of Stroke
Not yet recruiting
- Cerebrovascular Stroke
- (no location specified)
Jun 23, 2023
Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)
Recruiting
- Pulmonary Embolism
- ultrasound-assisted, catheter-directed thrombolysis
-
Milano, Italia, ItalyASST GOM Niguarda
Nov 21, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
May 24, 2023
Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- mFOLFOX6 + Cetuximab
- mFOLFOX 6
-
Shanghai, ChinaZhongshan hosptial, Fudan University
Jul 14, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen
Recruiting
- Pancreatic Cancer
- +3 more
- Bio-specimen Collection: Blood
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk
Recruiting
- Stimulant Abuse
- Criminal Behavior
- Decision task
-
Albuquerque, New MexicoThe Mind Research Network
Apr 25, 2023
Pressure-Volume Loop During High-Risk PCI
Recruiting
- Coronary Artery Disease
- High-risk percutaneous coronary intervention
-
Detroit, MichiganHenry Ford Hospital
Dec 6, 2022
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
-
Houston, TexasHouston Methodist
Dec 8, 2022
Clinical Research of Drug Holiday Based on MRD Detection in GIST
Recruiting
- Gastrointestinal Stromal Tumors
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 11, 2023
Cardiovascular Diseases Trial in Tartu (Informing study subjects about their high CVD polygenic risk score)
Active, not recruiting
- Cardiovascular Diseases
- Informing study subjects about their high CVD polygenic risk score
-
Tartu, EstoniaInstitute of Family Medicine and Public Health, University of Ta
Oct 28, 2022
Endotracheal Intubation Trial in Seoul (Intubation with VentiBronc Anchor endobronchial double-lumen tube, conventional
Recruiting
- Endotracheal Intubation
- Intubation with VentiBronc Anchor endobronchial double-lumen tube
- conventional double-lumen intubation
-
Seoul, Korea, Republic ofSeverance hospital
Sep 22, 2023
Prostate Cancer Trial in Beijing (Darolutamide+ADT)
Not yet recruiting
- Prostate Cancer
-
Beijing, ChinaPeking University First Hospital
Sep 1, 2023
Hepatocellular Carcinoma Trial in Tianjin (ultrasonic testing)
Recruiting
- Hepatocellular Carcinoma
- ultrasonic testing
-
Tianjin, Tianjin, China王芳
Nov 20, 2023
Based on Electronic Health RecOrds to Identify Patients at
Not yet recruiting
- Fabry Disease
- (no location specified)
Dec 20, 2022
Preeclampsia, Perinatal Haemorrhage Trial in Guangzhou (aspirin discontinuation, aspirin continuation)
Not yet recruiting
- Preeclampsia
- Perinatal Haemorrhage
- aspirin discontinuation
- aspirin continuation
-
Guangzhou, Guangdong, ChinaFANG HE
Oct 26, 2023
Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)
Recruiting
- Radiotherapy
- +3 more
- SBRT
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 2, 2023